Back
Strategy Vs. Insmed Industry Stock Comparison
Sell
50
MSTR
Strategy
Last Price:
$414.90
Seasonality Move:
12.21%
Buy
57
INSM
Insmed
Last Price:
$103.53
Seasonality Move:
-1.13%
Sell
50
Strategy (MSTR)
is a Sell
Is Strategy a Buy, Sell or Hold?
-
MSTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MSTR Stock Price Chart
MSTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 112.33 | Buy |
Relative Strength Index (14 RSI): | 50.49 | Buy |
Chaikin Money Flow: | -3454427 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (378.87 - 433.49) | Buy |
Bollinger Bands (100): | (302.7 - 411.66) | Buy |
INSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 27.18 | Buy |
Relative Strength Index (14 RSI): | 65.75 | Buy |
Chaikin Money Flow: | 1635844 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (97.94 - 103.96) | Buy |
Bollinger Bands (100): | (66.79 - 94.09) | Buy |
MSTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 436.14 | Sell |
20-day SMA: | 414.81 | Sell |
50-day SMA: | 397.38 | Buy |
200-day SMA: | 336.49 | Buy |
8-day EMA: | 407.25 | Buy |
20-day EMA: | 300.7 | Buy |
50-day EMA: | 163.99 | Buy |
200-day EMA: | 48.62 | Buy |
INSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.15 | Buy |
20-day SMA: | 100.5 | Buy |
50-day SMA: | 87.78 | Buy |
200-day SMA: | 76.94 | Buy |
8-day EMA: | 97.6 | Buy |
20-day EMA: | 71.2 | Buy |
50-day EMA: | 38.66 | Buy |
200-day EMA: | 11.44 | Buy |
Strategy Earnings Growth & MSTR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.03 per share, a decrease this year of $13.19 per share, and an increase next year of $16.05 per share.
Insmed Earnings Growth & INSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $1.59 per share.
Strategy Technical Analysis
Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Insmed Technical Analysis
Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |